Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

33.70 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gsk Plc ADR

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
35 36 Next >
Drugmaker GSK: Becoming a Healthier Value Stock
Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit. 
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
Baidu Says Ernie Bot Beats ChatGPT, Meta's WhatsApp Business Soars Past 200M Users, Walgreens Earnings Disappointment: Today's Top Stories
CNBC ChatGPT Vs. Baidu's Ernie Bot - Chinese Tech Giant Says Ernie Beat ChatGPT 
Via Benzinga
Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track
The FDA has granted Fast Track designation to GSK plc's (NYSE: 
Via Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other... 
Via Benzinga
Is GSK a Strong Buy Right Now?
The drugmaker ought to appeal to value and income investors. 
Via The Motley Fool
2 Stocks Defying Friday's Market Downturn
Stock markets opened lower as Wall Street took a pause from the bull run. 
Via The Motley Fool
Why Shares of CureVac Jumped This Week
The company, which focuses on mRNA therapies, began a phase 1 trial for its cancer vaccine candidate. 
Via The Motley Fool
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'. 
Via Benzinga
GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms
GSK settled with James Goetz for an undisclosed amount of money. But thousands of cases remain. 
Via Investor's Business Daily
Crypto Analyst Says Bitcoin Can Break $32K Level, Nikola Moves Forward With Test Road Trips Despite Weak Demand & Internal Conflict, Retailers' Subscriptions Under FTC Scrutiny: Today's Top Stories
Benzinga 
Via Benzinga
GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month
GSK plc (NYSE: GSK) has reached a confidential settlement with James Goet 
Via Benzinga
Trupanion, IonQ, 3M And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Intel Voices Plans To Restructure Manufacturing Business, Bumble's BFF App, Spirit AeroSystems To Stop Work At Kansas Plant Amid Workers Strike: Today's Top Stories
Reuters 
Via Benzinga
RSV Vaccines from Pfizer and GSK Gain CDC Advisory Committee's Favor for Older Adults
The US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines from Pfizer Inc (NYSE: PFE) and GSK... 
Via Benzinga
7 Healthcare Stocks to Make You the Millionaire Next Door
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making
From GSK plc
Via Business Wire
Pfizer's Elderly Vaccine Efficacy Drops Slightly After 18 Months, New Clinical Trials Reveal - CDC Advisory Panel Set To Vote Today On Recommended Use Of RSV Shots
Pfizer Inc's (NYSE: PFE) vaccine for elderly 60 and above was slightly less effective after 18 months, according to the company's clinical trial  
Via Benzinga
GSK's Recently Approved Vaccine Offers Long-Term Protection Against RSV in Older Adults, New Data Reveals
GSK plc (NYSE: GSK) announced  
Via Benzinga
GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons
From GSK plc
Via Business Wire
GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis B
From GSK plc
Via Business Wire
Sanofi Stock Is Trading Higher Today - Here's Why
Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to... 
Via Benzinga
3 Undervalued Consumer Stocks to Buy in June
These undervalued consumer stocks to buy could attract investor attention as possible hedges against inflation and a recession. 
Via InvestorPlace
3 Gene Testing Stocks to Buy Before They Take Off
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry. 
Via InvestorPlace
UK Gives Nod To Roomba Maker IRobot-Amazon Deal, Micron Plans To Invest In China Despite Restrictions, Baidu Secures Regulatory Nod for Self-Driving Taxi: Today's Top Stories
Benzinga 
Via Benzinga
2 Top Healthcare Stocks to Buy Right Now
The demand for healthcare sector goods and services is both predictable and growing. 
Via The Motley Fool
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M
Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that  
Via Benzinga
FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition
The FDA has extended the review period for GSK plc's (NYSE: 
Via Benzinga
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making... 
Via FinancialNewsMedia
ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected: Today's Top Stories
Benzinga Cable Giant CNN Chairman, CEO Chris Licht Moves Out 
Via Benzinga
GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults
The European Commission has approved GSK plc's (NYSE:  
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.